NEURO62

Session information

Japanese Poster Session

[Pj-30] Japanese Poster Session 30 Medical care for intractable diseases 01

Fri. May 21, 2021 11:30 AM - 12:10 PM Room 15 (ICC Kyoto 1F New Hall)

Hajime Arahata1, Megumi Hama2, Emi Nishio2, Takahiro Maruyama2, Mine Toda3, Hayato Une1, Akihiro Watanabe1, Nobutaka Sakae1, Yuji Kawano1, Akifumi Yamamoto1, Naofumi Sasagasako1 (1.NHO Omuta National Hospital, Department of Neurology, Japan, 2.NHO Omuta National Hospital, Department of Nursing, 3.NHO Omuta National Hospital, Department of Clinical Nutrition & Food services.)

Hideki Kimura1,6, Takashi Onohara2,6, Kento Yamaguchi3,6, Miwa Kanazashi3,6, Kosuke Akari4,6, Kenji Inoue5,6, Toshio Shimizu1, Kazushi Takahashi1 (1.Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan, 2.Department of Nursing, Tokyo Metropolitan Neurological Hospital, 3.Department of Rehabilitation, Tokyo Metropolitan Neurological Hospital, 4.Department of Anesthesiology, Tokyo Metropolitan Neurological Hospital, 5.Department of Pediatric neurology, Tokyo Metropolitan Neurological Hospital, 6.Respiratory Support Team, Tokyo Metropolitan Neurological Hospital, Japan)

Masamichi Ikawa1,2, Tomohisa Yamaguchi2, Chieko Kiyono1, Masao Kawatani1,3, Norimichi Shirafuji2, Osamu Yamamura2, Tadanori Hamano2, Ikue Hata1,4, Makoto Yoneda1,5, Yasunari Nakamoto1,6 (1.Department of Medical Genetics, University of Fukui Hospital, Japan, 2.Department of Neurology, University of Fukui Hospital, Japan, 3.Department of Pediatrics, University of Fukui Hospital, 4.Department of Pediatrics, Fukui Prefectural Hospital, 5.Faculty of Nursing and Social Welfare Sciences, Fukui Prefectural University, 6.Department of Gastroenterology, University of Fukui Hospital)

Akiyo Hineno1,2,3, Yui Kamijo2, Sachie Aoki3, Yuri Morozumi3, Takashi Fujihara4, Masaomi Takizawa5, Akinori Nakamura6,7 (1.Intractable Disease Care Center, Shinshu University Hospital, Japan, 2.Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan, 3.Nagano Prefecture Intractable Disease Consultation and Support Center, Japan, 4.KISSEI COMTEC CO.,LTD., 5.Central Corridor Communication 21, 6.Department of Clinical Research, National Hospital Organization Matsumoto Medical Center, 7.Third Department of Medicine, Shinshu University School of Medicine)

Masaya Oda1,3, Ayumi Oishi2, Emiko Oda2, Chizuru Akimoto2, Mariko Kameoka2, Hiromi Miyamoto3, Masashi Sakai3,4, Haruka Wakabayashi4, Hijiri Ito1, Yuishin Izumi5 (1.Department of Neurology, Mifukai Vihara Hananosato Hospital, Japan, 2.Department of Nursing, Mifukai Vihara Hananosato Hospital, 3.Support team for intractable neurological diseases, Mifukai Miyoshi Clinic of Neurology, Hananosato, Japan, 4.Regional medical liaison office, Mifukai Vihara Hananosato Hospital, 5.Department of Neurology, Tokushima University)

Yui Kamijo1, Akiyo Hineno1,2, Nao Hujiwara3, Masaomi Takizawa4, Yoshiki Sekijima1,2, Akinori Nakamura5,6 (1.Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan, 2.Intractable Disease Care Center, Shinshu University Hospital, 3.KISSEI COMTEC CO. LTD., 4.Central Corridor Communication 21, 5.Department of Clinical Research, National Hospital Organization Matsumoto Medical Center, 6.Third Department of Medicine, Shinshu University School of Medicine)